Stocktoria
RadNet, Inc. RDNT
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2001-12-12
RadNet, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.8B | $1.6B | $1.4B | $1.3B |
| Operating income | $62.0M | $104.6M | $98.7M | $46.4M | $82.6M |
| Income tax | $14.9M | $6.0M | $8.5M | $9.4M | $14.6M |
| Net income | -$18.7M | $2.8M | $3.0M | $10.7M | $24.7M |
| EPS (diluted) | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 |
| Operating cash flow | $298.8M | $233.0M | $220.9M | $146.4M | $149.5M |
| Cash & equivalents | $767.2M | $740.0M | $342.6M | $127.8M | $134.6M |
| Total assets | $3.8B | $3.3B | $2.7B | $2.4B | $2.1B |
| Total liabilities | $2.4B | $2.2B | $1.9B | $1.9B | $1.7B |
| Shareholders' equity | $1.4B | $1.1B | $813.4M | $491.5M | $346.2M |
Source: SEC EDGAR filings · CIK 0000790526 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.